Department of Neurology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan City, Shanxi Province, 030062, China.
Laboratory of Biochemistry and Molecular Biology, School of Basic Medical Science, Shanxi Medical University, Taiyuan City, Shanxi Province, 030002, China.
Curr Neurovasc Res. 2020;17(3):259-266. doi: 10.2174/1567202617666200415154822.
Ischemia-reperfusion (I/R) injury is a pathological feature of ischemic stroke. This study investigated the regulatory role of miR-485-5p in I/R injury.
SH-SY5Y cells were induced with oxygen and glucose deprivation/reoxygenation (OGD/R) to mimic I/R injury in vitro. Cells were transfected with designated constructs (miR-485- 5p mimics, miR-485-5p inhibitor, lentiviral vectors overexpressing Rac1 or their corresponding controls). Cell viability was evaluated using the MTT assay. The concentrations of lactate dehydrogenase, malondialdehyde, and reactive oxygen species were detected to indicate the degree of oxidative stress. Flow cytometry and caspase-3 activity assay were used for apoptosis assessment. Dual-luciferase reporter assay was performed to confirm that Rac family small GTPase 1 (Rac1) was a downstream gene of miR-485-5p.
OGD/R resulted in decreased cell viability, elevated oxidative stress, increased apoptosis, and downregulated miR-485-5p expression in SH-SY5Y cells. MiR-485-5p upregulation alleviated I/R injury, evidenced by improved cell viability, decreased oxidative markers, and reduced apoptotic rate. OGD/R increased the levels of Rac1 and neurogenic locus notch homolog protein 2 (Notch2) signaling-related proteins in cells with normal miR-485-5p expression, whereas miR- 485-5p overexpression successfully suppressed OGD/R-induced upregulation of these proteins. Furthermore, the delivery of vectors overexpressing Rac1 in miR-485-5p mimics-transfected cells reversed the protective effect of miR-485-5p in cells with OGD/R-induced injury.
This study showed that miR-485-5p protected cells following I/R injury via targeting Rac1/Notch2 signaling suggest that targeted upregulation of miR-485-5p might be a promising therapeutic option for the protection against I/R injury.
缺血再灌注(I/R)损伤是缺血性中风的一种病理特征。本研究探讨了 miR-485-5p 在 I/R 损伤中的调节作用。
体外采用氧葡萄糖剥夺/复氧(OGD/R)诱导 SH-SY5Y 细胞模拟 I/R 损伤。用指定构建体(miR-485-5p 模拟物、miR-485-5p 抑制剂、过表达 Rac1 的慢病毒载体及其相应对照)转染细胞。用 MTT 法评估细胞活力。检测乳酸脱氢酶、丙二醛和活性氧的浓度来指示氧化应激的程度。用流式细胞术和 caspase-3 活性测定法评估细胞凋亡。双荧光素酶报告实验证实 Rac 家族小 GTP 酶 1(Rac1)是 miR-485-5p 的下游基因。
OGD/R 导致 SH-SY5Y 细胞活力降低、氧化应激增强、细胞凋亡增加和 miR-485-5p 表达下调。miR-485-5p 的上调减轻了 I/R 损伤,表现在细胞活力提高、氧化标志物减少和凋亡率降低。在 miR-485-5p 正常表达的细胞中,OGD/R 增加了 Rac1 和神经发生 Notch 同源物蛋白 2(Notch2)信号相关蛋白的水平,而 miR-485-5p 的过表达成功抑制了 OGD/R 诱导的这些蛋白的上调。此外,在 miR-485-5p 模拟物转染细胞中过表达 Rac1 的载体的递送逆转了 miR-485-5p 在 OGD/R 诱导的损伤细胞中的保护作用。
本研究表明,miR-485-5p 通过靶向 Rac1/Notch2 信号保护细胞免受 I/R 损伤,提示靶向上调 miR-485-5p 可能是一种有前途的治疗 I/R 损伤的选择。